logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. The National Cancer Data Base report on non-Hodgkin's lymphoma.

    Article - En anglais

    BACKGROUND

    The National Cancer Data Base (NCDB) has reported on many malignancies occurring in men and women in the U. S. from>1400 contributing hospitals.

    The current report on non-Hodgkin's lymphoma (NHL) is a companion to an upcoming Patient Care Evaluation study of this relatively common and serious cancer.

    METHODS

    This report is comprised of all NHL cases submitted to the NCDB divided into two diagnostic-year groups : 1985-1988 and 1990-1993.

    Variables routinely collected by hospital cancer registries have been analyzed to report on patterns of diagnosis and treatment.

    RESULTS

    High grade NHL cases were more likely to be Stage IV (40.8%) than were low or intermediate grade cases (34.8% and 32.5%, respectively).

    Patients with NHL arising from lymph node sites tended to present with more advanced disease (55.8% with Stages III and IV disease), whereas patients with NHL arising from extranodal sites and non-lymph node nodal sites presented at an earlier stage (64.7% and 74.0%, respectively, with Stage I or Stage II disease).

    Approximately 67% of all patients underwent chemotherapy, whereas only 25% underwent surgery or radiation.

    By histology, 5-year survival was 68.8% for low grade disease, 51.9% for intermediate grade disease, and 45.8% for high grade disease ; by stage, survival rates ranged from 73.5% for Stage I to 42.9% for Stage IV disease. (...)

    Mots-clés Pascal : Lymphome non hodgkinien, Homme, Base donnée, Etats Unis, Amérique du Nord, Amérique, Cancérologie, Traitement, Pronostic, Survie, Etude statistique, Informatique biomédicale, Hémopathie maligne, Lymphoprolifératif syndrome, Registre spécifique

    Mots-clés Pascal anglais : Non Hodgkin lymphoma, Human, Database, United States, North America, America, Cancerology, Treatment, Prognosis, Survival, Statistical study, Biomedical data processing, Malignant hemopathy, Lymphoproliferative syndrome

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 98-0098361

    Code Inist : 002B19B. Création : 22/06/1998.